Chronic Lymphocytic Leukemia

Therapeutische Umschau. Revue thérapeutique
Heike Schwarb, Dominik Heim

Abstract

Chronic Lymphocytic Leukemia Abstract. CLL is an indolent B-cell lymphoma characterized by a leukemic course. It is clinically and biologically very heterogeneous. The disease is preceded by a condition called monoclonal B lymphocytosis (MBL). The treatment of CLL has changed dramatically in recent years. Chemoimmunotherapy is being replaced by new molecularly targeted therapeutic modalities like B cell receptor inhibitors and BCL-2 regulators of programmed cell death. When to initiate therapy and what "new" drug combinations to use in which line of treatment are issues currently addressed in clinical trials.

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Ryōikibetsu shōkōgun shirīzu
S Ito, S Kuriya
Cancer Control : Journal of the Moffitt Cancer Center
Yvonne M Mowery, M C Lanasa
F1000prime Reports
Eugen TauschStephan Stilgenbauer
© 2021 Meta ULC. All rights reserved